Our aims were to compare the two strategies of AMP delivery with respect to their effectiveness in alleviating chemically induced colitis in mice, to understand the impact of each strategy on the host microbiota, and to determine if the mode of action of hCAP18 on the disease is dependent on its modulation of the gut ecosystem of the host. Here, CAMP is linked to colitis.